Brown Advisory Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,941
Closed -$282K 409
2017
Q3
$282K Buy
1,941
+37
+2% +$5.04K 0.06% 272
2017
Q2
$247K Buy
1,904
+16
+0.8% +$1.96K 0.06% 283
2017
Q1
$234K Sell
1,888
-3,552
-65% -$425K 0.06% 278
2016
Q4
$630K Buy
5,440
+1,773
+48% +$197K 0.17% 133
2016
Q3
$382K Buy
3,667
+59
+2% +$6.38K 0.11% 198
2016
Q2
$357K Sell
3,608
-255
-7% -$26.4K 0.11% 192
2016
Q1
$388K Buy
3,863
+243
+7% +$25K 0.13% 168
2015
Q4
$433K Buy
3,620
+254
+8% +$29.4K 0.15% 166
2015
Q3
$364K Buy
3,366
+20
+0.6% +$2.48K 0.13% 175
2015
Q2
$387K Buy
3,346
+27
+0.8% +$3.09K 0.13% 191
2015
Q1
$382K Buy
3,319
+261
+9% +$31.2K 0.13% 179
2014
Q4
$342K Sell
3,058
-45
-1% -$4.75K 0.12% 180
2014
Q3
$294K Buy
+3,103
New +$280K 0.11% 206

Other funds holding CELG

Brown Advisory Securities's CELG Position: Q4 2017 in Review

Brown Advisory Securities sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,941 shares — an estimated $282K sold.

Brown Advisory Securities first reported a position in CELG in Q3 2014 and held it in 13 quarters. The position peaked at $630K in Q4 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Brown Advisory Securities reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Brown Advisory Securities sold 1,941 Celgene Corp shares in Q4 2017, an estimated $282K.
  • Brown Advisory Securities first reported a position in Celgene Corp in Q3 2014 and held it in 13 quarters.
  • Brown Advisory Securities's Celgene Corp position peaked at $630K in Q4 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Brown Advisory Securities's 13F filing for Q4 2017, filed 12 Feb 2018.